Hot Features
プレミアム
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat l... Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.3 | 54.5454545455 | 0.55 | 1 | 0.45 | 73114 | 0.7558621 | CS |
| 4 | -4.04 | -82.6175869121 | 4.89 | 4.89 | 0.25 | 82413 | 0.65209592 | CS |
| 12 | -4.15 | -83 | 5 | 8 | 0.25 | 43924 | 0.66525372 | CS |
| 26 | -7.65 | -90 | 8.5 | 9 | 0.25 | 36081 | 0.67442746 | CS |
| 52 | -19.15 | -95.75 | 20 | 23 | 0.25 | 23121 | 0.710908 | CS |
| 156 | -19.15 | -95.75 | 20 | 23 | 0.25 | 23121 | 0.710908 | CS |
| 260 | -19.15 | -95.75 | 20 | 23 | 0.25 | 23121 | 0.710908 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
